{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:14:13Z","timestamp":1792091653755,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.compbiomed.2023.107572","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T06:06:40Z","timestamp":1697090800000},"page":"107572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comprehensive In silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of cholangiocarcinoma"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-6754","authenticated-orcid":false,"given":"Manju Nidagodu","family":"Jayakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-1062","authenticated-orcid":false,"given":"Jibran Sualeh","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0887-2893","authenticated-orcid":false,"given":"Mainak","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3216-8759","authenticated-orcid":false,"given":"Sainitin","family":"Donakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2023.107572_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.compbiomed.2023.107572_bib3","first-page":"5","article-title":"Gastrointestinal and pancratohepatobiliary cancers: a comprehensive review on epidemiology and risk factors worldwide, Middle East","volume":"14","author":"Hormati","year":"2022","journal-title":"J Dig Dis"},{"key":"10.1016\/j.compbiomed.2023.107572_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.compbiomed.2023.107572_bib5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/jca.68264","article-title":"The new insight of treatment in Cholangiocarcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.107572_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133222","article-title":"Next-Generation biomarkers for cholangiocarcinoma,","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2023.107572_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236569","article-title":"Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases","volume":"15","author":"Peltonen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2023.107572_bib9","first-page":"9","article-title":"The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas","volume":"15","author":"Stroescu","year":"2006","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.compbiomed.2023.107572_bib10","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.7150\/jca.44697","article-title":"CK19-positive hepatocellular carcinoma is a characteristic subtype","volume":"11","author":"Zhuo","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.107572_bib11","first-page":"11","author":"Guang","year":"2019"},{"key":"10.1016\/j.compbiomed.2023.107572_bib12","article-title":"Protein homeostasis in aging and cancer","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104691","article-title":"HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy","volume":"123","author":"Shu","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajpath.2011.09.010","article-title":"Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma","volume":"180","author":"Sato","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib15","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1535-7163.MCT-15-0069","article-title":"Heat shock protein 90 is a potential therapeutic target in cholangiocarcinoma","volume":"14","author":"Shirota","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.compbiomed.2023.107572_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22369-9","article-title":"The landscape of molecular chaperones across human tissues reveals a layered architecture of core and variable chaperones","volume":"12","author":"Shemesh","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2023.107572_bib17","first-page":"9","article-title":"Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy","author":"Yun","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.compbiomed.2023.107572_bib18","first-page":"188","article-title":"Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy","volume":"15","author":"Calderwood","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.compbiomed.2023.107572_bib19","doi-asserted-by":"crossref","first-page":"82123","DOI":"10.18632\/oncotarget.18899","article-title":"Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation","volume":"8","author":"Tracz-Gaszewska","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2023.107572_bib20","first-page":"935","article-title":"The involvement of small heat shock protein in chemoresistance in ovarian cancer - in vitro study","volume":"20","author":"Wyciszkiewicz","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.compbiomed.2023.107572_bib21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.2174\/1871520618666180817114952","article-title":"The role of heat shock proteins in cisplatin resistance","volume":"18","author":"Krawczyk","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.compbiomed.2023.107572_bib22","doi-asserted-by":"crossref","first-page":"33658","DOI":"10.18632\/oncotarget.5603","article-title":"GRP78 confers the resistance to 5-FU by activating the c-Src\/LSF\/TS axis in hepatocellular carcinoma","volume":"6","author":"Gu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2023.107572_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020243","article-title":"HSP90alpha mediates sorafenib resistance in human hepatocellular carcinoma by necroptosis inhibition under hypoxia","volume":"13","author":"Liao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.compbiomed.2023.107572_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide\u2013identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Translational Medicine Communications"},{"key":"10.1016\/j.compbiomed.2023.107572_bib25","series-title":"Drug Repurposing-Hypothesis, Molecular Aspects and Therapeutic Applications","article-title":"Drug repurposing (DR): an emerging approach in drug discovery","author":"Rudrapal","year":"2020"},{"key":"10.1016\/j.compbiomed.2023.107572_bib26","series-title":"A Comprehensive Enumeration of the Human Proteostasis Network. 1. Components of Translation, Protein Folding, and Organelle-specific Systems","author":"Consortium","year":"2022"},{"key":"10.1016\/j.compbiomed.2023.107572_bib27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.celrep.2014.09.042","article-title":"A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease","volume":"9","author":"Brehme","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiomed.2023.107572_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2164-9-488","article-title":"BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams","volume":"9","author":"Hulsen","year":"2008","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2023.107572_bib29","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.107572_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.compbiomed.2023.107572_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.compbiomed.2023.107572_bib32","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.107572_bib33","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.107572_bib34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2023.107572_bib35","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2023.107572_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/pro.380","article-title":"Crystal structures of truncated alphaA and alphaB crystallins reveal structural mechanisms of polydispersity important for eye lens function","volume":"19","author":"Laganowsky","year":"2010","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2023.107572_bib37","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/pro.3450","article-title":"Structural enzymology binding studies of the peptide-substrate-binding domain of human collagen prolyl 4-hydroxylase (type-II): high affinity peptides have a PxGP sequence motif","volume":"27","author":"Murthy","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2023.107572_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"Le Guilloux","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.compbiomed.2023.107572_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.627574","article-title":"An open access database of licensed cancer drugs","volume":"12","author":"Pantziarka","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2023.107572_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.compbiomed.2023.107572_bib43","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2023.107572_bib44","series-title":"Advances in Computational Modeling and Simulation","first-page":"85","article-title":"Identification of potential inhibitors against SARS-CoV-2 3CLpro, PLpro, and RdRP proteins: an in-silico approach","author":"Jayakumar","year":"2022"},{"key":"10.1016\/j.compbiomed.2023.107572_bib45","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1080\/07391102.2021.1977181","article-title":"In silico and in vitro assays reveal potential inhibitors against 3CL(pro) main protease of SARS-CoV-2","volume":"40","author":"Iype","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2023.107572_bib46","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Source Drug Discovery, A. Lynn, g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2023.107572_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2023.107572_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1146\/annurev.biochem.052308.114844","article-title":"Biological and chemical approaches to diseases of proteostasis deficiency","volume":"78","author":"Powers","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.compbiomed.2023.107572_bib49","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1371\/journal.pgen.0020088","article-title":"Why do hubs tend to be essential in protein networks?","volume":"2","author":"He","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.compbiomed.2023.107572_bib50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib51","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches","volume":"20","author":"Sun","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107572_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1379\/CSC-99r.1","article-title":"Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications","volume":"10","author":"Ciocca","year":"2005","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.compbiomed.2023.107572_bib53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.compbiomed.2023.107572_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa224","article-title":"Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis","volume":"22","author":"Long","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2023.107572_bib55","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.31557\/APJCP.2022.23.8.2573","article-title":"Beta-eudesmol inhibits the migration of cholangiocarcinoma cells by suppressing epithelial-mesenchymal transition via PI3K\/AKT and p38MAPK modulation","volume":"23","author":"Acharya","year":"2022","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.compbiomed.2023.107572_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neo.2020.11.002","article-title":"Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival","volume":"23","author":"Muhammad","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.compbiomed.2023.107572_bib57","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.3892\/mmr.2015.3865","article-title":"Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal-regulated kinase signaling pathway","volume":"12","author":"Vanichapol","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.compbiomed.2023.107572_bib58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40164-022-00365-z","article-title":"Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in mice","volume":"12","author":"Rashidieh","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib59","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182407","article-title":"High alpha B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer","volume":"39","author":"Tan","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.compbiomed.2023.107572_bib60","article-title":"Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer","volume":"98","author":"Tao","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.compbiomed.2023.107572_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.01.012","article-title":"alphaB-crystallin: portrait of a malignant chaperone as a cancer therapeutic target","volume":"160","author":"Malin","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2023.107572_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2015.14","article-title":"alphaB-crystallin expression in breast cancer is associated with brain metastasis","volume":"1","author":"Voduc","year":"2015","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.compbiomed.2023.107572_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281009","article-title":"The small heat shock protein alphaB-Crystallin protects versus withaferin A-induced apoptosis and confers a more metastatic phenotype in cisplatin-resistant ovarian cancer cells","volume":"18","author":"Carmichael","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2023.107572_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbagen.2015.09.017","article-title":"Phosphorylation of alphaB-crystallin: role in stress, aging and patho-physiological conditions","volume":"1860","author":"Bakthisaran","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.compbiomed.2023.107572_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12192-020-01175-0","article-title":"AlphaB-crystallin and breast cancer: role and possible therapeutic strategies","volume":"26","author":"Caporossi","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.compbiomed.2023.107572_bib66","first-page":"39","article-title":"The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer","volume":"9","author":"Sirhan","year":"2022","journal-title":"Mil Med Res"},{"key":"10.1016\/j.compbiomed.2023.107572_bib67","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1016\/j.annonc.2022.04.440","article-title":"LBA-2 Primary analysis of MOUNTAINEER: a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC","volume":"33","author":"Strickler","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib68","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.20.00775","article-title":"Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial","volume":"38","author":"Lin","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib69","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1016\/j.annonc.2022.04.164","article-title":"P-74 SGNTUC-019: phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: biliary tract cancer cohort (trial in progress)","volume":"33","author":"Bekaii-Saab","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib70","doi-asserted-by":"crossref","first-page":"S1073","DOI":"10.1016\/j.annonc.2021.08.1546","article-title":"1437TiP Phase Ib\/II, open label, dose escalation and expansion trial of tucatinib in combination with trastuzumab and oxaliplatin-based chemotherapy in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in Progress)","volume":"32","author":"Park","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-1","article-title":"Prolyl-4-hydroxylase alpha subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition","volume":"14","author":"Xiong","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.compbiomed.2023.107572_bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2019.06.048","article-title":"Aspirin targets P4HA2 through inhibiting NF-kappaB and LMCD1-AS1\/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.compbiomed.2023.107572_bib73","article-title":"P4HA2-mediated HIF-1alpha stabilization promotes erdafitinib-resistance in FGFR3-alteration bladder cancer","volume":"37","author":"Li","year":"2023","journal-title":"Faseb. J."},{"key":"10.1016\/j.compbiomed.2023.107572_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1406853","article-title":"P4HA2 promotes epithelial-to-mesenchymal transition and glioma malignancy through the collagen-dependent PI3K\/AKT pathway","author":"Lin","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.compbiomed.2023.107572_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41419-022-04816-7","article-title":"Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis","volume":"13","author":"Chang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiomed.2023.107572_bib76","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/cncr.31872","article-title":"A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma","volume":"125","author":"Sun","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.compbiomed.2023.107572_bib77","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.annonc.2020.05.018","article-title":"Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced\/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial","volume":"31","author":"Demols","year":"2020","journal-title":"Ann. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.compbiomed.2023.107756","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523010375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523010375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:55:10Z","timestamp":1736362510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482523010375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":77,"alternative-id":["S0010482523010375"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107572","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.compbiomed.2023.107756","asserted-by":"object"}]},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive In silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107572"}}